Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache
Gutierrez, Genaro, McCormick, Zachary L. , Engle, Mitchell, Gilmore, Christopher A , Pingree, Matthew J. , Pope, Jason E. , DiBenedetto, David , Kissoon, Narayan , Sayal, Puneet, Zurn, Claire A. , Boggs, Joseph W. , DiBenedetto, David J , Kissoon, Narayan R , Crosby, Nathan D , Boggs, Joseph W , Pingree, Matthew , McCormick, Zachary L , Crosby, Nathan D.

Headache: The Journal of Head and Face Pain | May 20, 2025 | Volume: 65 | Issue: 10 | Pages: 1776-1787

10.1111/head.14948 | PMID 40391557 Get It

Abstract Objective The aim of this study was to evaluate the efficacy and safety of a 60‐day peripheral nerve stimulation (PNS) treatment targeting the occipital nerves for reducing pain and improving function in individuals diagnosed with cervicogenic headache or occipital neuralgia. Background Headache conditions are prevalent and commonly disabling, and conventional therapeutic strategies are often insufficient. Development of a percutaneous 60‐day PNS treatment has created new opportunities to evaluate PNS of the occipital nerves. Methods This study was an institutional review board‐approved, multicenter, prospective, single‐arm study that enrolled participants from October 2022 to March 2024. Participants with cervicogenic headache or occipital neuralgia received a 60‐day PNS treatment targeting the occipital nerves. The primary endpoint was the proportion reporting clinically significant (≥30%) reductions in average pain and/or pain interference at end of treatment (EOT). Additional analysis included the proportion of participants with ≥50% reduction in average pain intensity and/or pain interference and additional outcomes including Patient Global Impression of Change, six‐item Headache Impact Test, and Neck Disability Index. Results At EOT, 90% of participants (18/20) met the primary endpoint. Further, 85% (17/20) and 83% (15/18) reported ≥50% reductions in pain and/or pain interference at EOT and 3 months, respectively. Clinically meaningful improvements were observed in functional and headache‐related disability and quality‐of‐life measures. All study‐related adverse events were non‐serious. Conclusion Most participants reported significant reductions in pain and/or pain interference following 60‐day PNS targeting the occipital nerves. Outcomes through 3 months demonstrate how 60‐day PNS offers an effective approach for the treatment of headache.
Significant Microvascular Abnormalities Present in Autonomic Nervous System Dysfunction: Results of a Cross-Sectional Study
Mumtaz, Sehreen , Arca, Karissa N., Majithia, Vikas , Cheshire, William P. , Hodge, David, Berianu, Florentina , Arca, Karissa, Cheshire, William P , Majithia, Vikas , Mumtaz, Sehreen

Biomedicines | May 20, 2025 | Volume: 13 | Issue: 5 | Pages: 1242

10.3390/biomedicines13051242 | PMID 40427067 Get It

Purpose: The prevalence and phenotype of capillaroscopic abnormalities in patients with autonomic nervous system dysfunction have not yet been investigated. Multiorgan involvement in dysautonomia entails abnormal vasoreactivity. We aim to correlate the diagnosis of autonomic dysfunction with certain clinical manifestations, which may provide prognostic or diagnostic information using a noninvasive technique, i.e., nailfold video capillaroscopy (NVC). Methods: Patients with autonomic nervous system dysfunction were recruited from rheumatology and neurology clinics with voluntary NVC procedures from 31 January 2024 to 10 January 2024, and a comparison with normal controls was performed. Additional recorded information include demographics and diagnoses of autonomic dysfunction types by autonomic testing, including, but not limited to, the following: reflex screen, sweat test, Valsalva maneuver, nerve fiber density, electromyography (EMG), serology, and history of autoimmune diseases. NVC was performed on a total of 27 patients. This study was approved by the Mayo Clinic Institutional Review Board. Results: The autonomic dysfunction group consisted of small-fiber neuropathy (37%), orthostatic hypotension (48%), autonomic neuropathy (30%), limited autonomic neuropathy (7%), postural orthostatic tachycardia syndrome (POTS) (7%), and connective tissue disease (7%), among other types. Patients with autonomic dysfunction had statistically significant increases in microhemorrhages, dilated capillaries, and ramifications when compared to controls. Conclusions: Autonomic dysfunction was associated with statistically significant microvascular abnormalities compared to normal controls with a distinct NVC pattern. There was a statistically significant correlation between age and BMI with microvascular abnormalities. Here, we demonstrate the diagnostic potential of NVC in autonomic dysfunction and advocate for further study of capillary structures in autonomic dysfunction.
Sex differences in prodromal dementia with Lewy bodies using the National Alzheimer's Coordinating Center data
Ferman, Tanis J. , Chrenka, Ella , Chiu, Shannon , Chiu, Shannon Y , Ferman, Tanis J , Wyman‐Chick, Kathryn A , Armstrong, Melissa J. , Patel, Bhavana , Barrett, Matthew J. , Bayram, Ece

Alzheimer's & Dementia | May 20, 2025 | Volume: 21 | Issue: 5 | Pages: No page available

10.1002/alz.70275 | PMID 40390234 Get It

AbstractINTRODUCTIONMales are disproportionately represented in dementia with Lewy bodies (DLB). Little is known regarding sex differences in cognitive, neuropsychiatric, and motor features of the prodromal stage of DLB.METHODSWe used National Alzheimer's Coordinating Center longitudinal data to examine cognitive, neuropsychiatric, and motor features in 120 males and 23 females 2 years prior to a clinical diagnosis of DLB.RESULTSMales were more likely than females to present with two or more core DLB clinical features 2 years prior to obtaining a diagnosis of dementia. Rapid eye movement sleep behavior disorder, cognitive fluctuations, bradykinesia, and rigidity were more common in males than females. Neuropsychological test performance was similar between groups.DISCUSSIONIn prodromal DLB, males exhibit a greater number of core features than females. Core DLB features may fall short in identifying females at risk. Additional work is needed to better understand the clinical profile of prodromal DLB in females.Highlights There are sex differences in the presentation and course of neurodegenerative disease. Findings from the National Alzheimer's Coordinating Center Uniform Data Set suggest there are sex differences in prodromal DLB symptoms. Females were less likely to demonstrate core clinical features of DLB prior to dementia diagnosis. This information can help inform clinical diagnostic criteria for prodromal DLB.
Novel algorithms & blood‐based biomarkers: Dementia detection and care transitions for persons living with dementia in the emergency department
Saxena, Saket , Carpenter, Christopher R. , Floden, Darlene , Meldon, Stephen W. , Hwang, Ula , Carpenter, Christopher R , Meldon, Stephen , Hwang, Ula , Taylor, Richard Andrew

Alzheimer's & Dementia | May 20, 2025 | Volume: 21 | Issue: 5 | Pages: No page available

10.1002/alz.70287 | PMID 40390207 Get It

AbstractPersons Living with Dementia (PLWD), diagnosed or undiagnosed, have high Emergency Department (ED) use. Identification of such patients poses significant challenges for emergency clinicians with considerable downstream implications on patients, care partners, and healthcare systems. With the advent of Geriatric Emergency Departments (GEDs) there is an opportunity to understand and improve care of PLWDs in EDs with effective allocation of resources and the development of novel techniques to better support detecting those at risk, communicating findings, and coordinating care for such patients. Advances have been made leveraging Electronic Health Record (EHR) data to risk stratify patients for dementia in the hope that those at high‐risk may benefit from further evaluation. The promise of multiple blood‐base biomarkers (BBM) as a future modality to improve detection of those at risk of dementias, will also have the potential to advance the delivery of care of PLWD and their care partners in EDs.Highlights EDs have an integral role in delivering care for Person Living with Dementia and their care partners. High acuity and fast paced ED environment and other barriers makes it difficult to identify Person Living with Dementia. EHR‐based risk stratification algorithms can identify patients at risk for Dementia in ED and outpatient settings. Use of Blood‐Based Biomarkers in the ED setting is novel and considerations of its use and implications need to be studied. EHR based risk stratification algorithm and Blood Based Biomarkers when used judiciously have the potential to overcome some of the known barriers to identify and improve care for Person Living with Dementia as they transition through EDs.
Incident Heart Failure is Common and Underrecognized in Patients with Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease
Wegermann, Kara , Chouairi, Fouad , Karachaliou, Georgia Sofia , Ahlers, Carolyn , Miller, Kaela, Biering‐Sørensen, Tor , Diehl, Anna Mae , Moylan, Cynthia A. , Fudim, Marat , Abdelmalek, Manal F. , Moylan, Cynthia A , Au, Sandra

European Journal of Heart Failure | May 20, 2025 | Volume: 27 | Issue: 11 | Pages: 2041-2048

10.1002/ejhf.3697 | PMID 40389356 Get It

ABSTRACT Aims Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with heart failure (HF), independent of shared risk factors. Our aim was to describe the incidence of HF in patients with biopsy-proven MASLD. Methods and results We followed patients with biopsy-proven MASLD from the prospective Duke NAFLD Biorepository and Clinical Database from liver biopsy (2007–2013) until death or 5 January 2023. Clinical and echocardiographic data were abstracted via manual chart review. Incident HF was defined as one of the following: (1) hospitalization for HF, (2) medical record diagnosis of HF, (3) ≥1 sign/symptom of HF and elevated natriuretic peptide, or (4) diastolic dysfunction on transthoracic echocardiography with ≥1 sign/symptom of HF. Univariable and multivariable logistic regression models were evaluated. Overall, 570 patients with biopsy-proven MASLD were included. The mean age was 49.5 years, 42.5% were male and 87.0% were non-Hispanic White. Ten patients (1.8%) had baseline HF, leaving 560 patients to assess for incident HF. Over a median follow up of 4009 days (11.0 years) (interquartile range 2270–4672 days), 100 (17.9%) patients developed incident HF while 268 (47.9%) met criteria for HF suspicion. In a multivariable model, increasing age (odds ratio [OR] 1.05, 95% confidence interval [CI] 1.02–1.08, p < 0.001) and female sex (OR 1.85, 95% CI 1.12–3.04, p = 0.02) were associated with incident HF. Conclusions We found a high incidence of HF in patients with biopsy-proven MASLD. Despite nearly half of patients having suspected HF, very few carried a chart diagnosis. Screening for HF in high-risk patients and establishment of formal care pathways to address early HF may reduce morbidity and mortality.
Cold snare endoscopic resection for large colon polyps: a randomised trial
Pohl, Heiko , Rex, Douglas K. , Barber, Jeremy, Moyer, Matthew T. , Elmunzer, B. Joseph , Rastogi, Amit , Gordon, Stuart R. , Zolotarevsky, Eugene, Levenick, John M. , Aslanian, Harry R., Elatrache, Mazen, Renteln, Daniel von , Brahmbhatt, Bhaumik , Keswani, Rajesh N. , Kumta, Nikhil A. , Smith, Zachary L. , Ghanimeh, Mouhanna K. Abu, Simmer, Stephen, MacKenzie, Todd A. , Piraka, Cyrus , von Renteln, Daniel , Smith, Zachary L , Piraka, Cyrus , Wallace, Michael B. , Pleskow, Douglas K. , Sanaei, Omid

Gut | May 20, 2025 | Volume: 74 | Issue: 11 | Pages: 1804-1813

10.1136/gutjnl-2025-335075 | PMID 40393701 Get It

Background Complications of endoscopic mucosal resection (EMR) of large colorectal polyps remain a concern. Objective We aimed to compare safety and efficacy of cold EMR (without electrocautery) to hot EMR (with electrocautery) of large colorectal polyps. Design In this multicentre randomised trial, patients with any large (≥20 mm) non-pedunculated colon polyp were assigned to cold or hot EMR (primary intervention), and to submucosal injection with a viscous or non-viscous solution (secondary intervention) following a 2×2 design. The primary outcome was the rate of severe adverse events (SAEs). The secondary outcome was polyp recurrence. In this study, we report results of the primary intervention. Results 660 patients were randomised and analysed. An SAE was observed in 2.1% of patients in the cold EMR group and in 4.3% in the hot EMR group (p=0.10) (per protocol analysis 1.4 vs 5.0%, p=0.017) with fewer perforations following cold EMR (0%) compared with hot EMR (1.6%, p=0.028). Postprocedure bleeding did not differ (1.5% vs 2.2%, p=0.57). The effect of cold resection was independent of the type of submucosal injection solution, polyp size or antithrombotic medications. Recurrence was detected in 27.6% and 13.6% in the cold and hot EMR groups, respectively (p<0.001). Recurrence was not significantly different for 20–29 mm polyps (18.6% vs 13.4%, p=0.24) and for sessile serrated polyps (14.1% vs 8.5%, p=0.33). Conclusion Universal application of cold EMR did not significantly lower SAEs (unless cold EMR could be completed) and doubled the recurrence rate compared with hot EMR. Trial registration details ClinicalTrials.gov, number: NCT03865537 .
Clinical Differences Among Histological Categories of Sarcoma: Insights from 97,062 Patients
Shah, Ahmed , Mutter, Robert W. , Xu‐Welliver, Meng , Shah, Ahmed , Xu-Welliver, Meng , Han, Yiqun, Yao, Yuan , Shah, Ahmed , Han, Yiqun

Cancers | May 20, 2025 | Volume: 17 | Issue: 10 | Pages: 1706

10.3390/cancers17101706 | PMID 40427203 Get It

Objectives: To evaluate the clinical heterogeneity of sarcomas by examining associations between histological subtypes, metastatic patterns, treatment modalities, and survival outcomes. Methods: We analyzed data from 97,062 adult patients diagnosed with sarcoma between 2000 and 2020, using the Surveillance, Epidemiology, and End Results (SEER) database. Fourteen histological subtypes were included. Propensity score matching (PSM) was employed to adjust for baseline differences, and Cox proportional hazards models were used to identify prognostic variables. Results: The most prevalent subtypes were sarcoma not otherwise specified (31.9%), leiomyosarcoma (17.1%), and liposarcoma (13.9%). Metastatic patterns differed significantly by subtype; liver metastases were most common in sarcomas with small blue round cell (SBRC) features (8.9%) and stromal sarcoma (6.1%), while lung metastases were frequently observed in Ewing sarcoma (10.0%) and rhabdomyosarcoma (9.7%). Median overall survival (mOS) varied widely, ranging from 234 months in chondrosarcoma to 16–20 months in rhabdomyosarcoma and SBRC sarcoma. Overall, patients with primary sarcoma had significantly better survival than those with treatment-related disease (119.0 vs. 45.0 months, p < 0.0001), with this trend consistent across most subtypes. Treatment responses were subtype- and size-dependent. For instance, surgery plus radiotherapy improved outcomes in giant cell sarcoma regardless of tumor size, whereas chemotherapy provided benefit only in tumors larger than 5 cm. Combined surgery and radiotherapy offered additional survival benefit in select subtypes, including chordoma, leiomyosarcoma (>5 cm), and synovial sarcoma (<5 cm). Conclusions: Sarcomas exhibit substantial clinical and prognostic heterogeneity across histological subtypes. These findings underscore the importance of subtype-specific, individualized treatment strategies in optimizing patient outcomes.
Consensus Statement on Robotic Nipple Sparing Mastectomy Expert Panel
Ryu, Jai Min , Mok, Chi Wei , Toesca, Antonio , Lai, Hung‐Wen , Kuo, Wen‐Ling , Cheng, Fiona Tsui-Fen , Song, Seung Yong , Johnson, Jeffrey , Shin, Hyukjai , Park, Hyung Seok , Johnson, Jeffrey E , Cheng, Fiona Tsui-Fen

Journal of Breast Cancer | May 19, 2025 | Volume: 28 | Issue: 3 | Pages: 180

10.4048/jbc.2025.0030 | PMID 40432351 Get It

A Scoping Review of Interventions to Promote Diversity, Equity, and Inclusion in the United States Healthcare Workforce
Hill, Katherine A. , Austin, Andrew, Austin, Andrew W, Hill, Katherine Ann , Enders, Felicity

Journal of Medical Education and Curricular Development | May 19, 2025 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/23821205251333034 | PMID 40395665 Get It

Background Diversifying the healthcare workforce is critical to achieving a healthier, more equitable society. Objectives The objective of this literature review was to examine and synthesize the literature on interventions to promote diversity, equity, and inclusion (DEI) in people who are currently enrolled in the workforce or in a terminal degree/training program and who are located in the following institution types: medical centers; healthcare organizations; and schools of dentistry, medicine, nursing, nurse practitioners, physician assistants, and public health. Methods A literature search was performed on November 2, 2023 in Ovid MEDLINE ® . We reviewed titles and abstracts of all retrieved articles from 2000 forward and the full text of articles included in the final review. We included English-language articles published in peer-reviewed journals that detailed 1 or more interventions to promote DEI in the United States and United States territories. All data included in the final review was extracted by a single investigator and charted using an Excel spreadsheet. Results The authors identified 55 articles for inclusion, 4 of which aggregated and analyzed data from many interventions. The remainder detailed 52 interventions across 25 states and Puerto Rico. Most articles did not include a comparison group (38, 69%). The types of interventions identified were: institutional change (14, 27%), mentorship (13, 25%), development programs (13, 25%), pathway programs (5, 10%), financial support (2, 4%), and workshops (2, 4%). Three (6%) interventions could not be categorized. Most studies detailed interventions in medicine (28, 54%) and nursing (11, 21%), focused on racial and ethnic (42, 81%) and/or sex (12, 23%) diversity, and targeted students (33, 64%) and/or faculty/staff (28, 54%). Conclusion Many different types of interventions have been trialed to promote workforce DEI in the United States healthcare workforce. These efforts must continue to achieve a diverse and equitable healthcare workforce.